Epidemiological Characteristics and Prognosis Factors of Cancer Patients Admitted at French Emergency Departments

NCT03393260 | Completed

• 1 other identifier: IRU2017
• Study Type: observational
• Target: 1,380
• Locations: 1 country
• Sites: 1

Brief Summary

Patients with cancer or hematological malignancy are susceptible to present acute complications linked to their disease or to their specific treatments (dyspnea, sepsis, coma, hemorrhagic syndrome). Emergency physicians are in first line when these complications arise and have to face with some complex situations in which informations about patient malignancy or prognosis may be lacking. Nowadays, there is very few epidemiological data published concerning how cancer patient use Emergency Departments (EDs) and cancer patient care delivery in the EDs. Thus, an observational multicenter prospective cross-sectional study is conducted to study the prevalence of cancer patients admitted to French EDs, and to describe the different reasons for cancer patients to seek care in EDs with their prevalence and underscore those linked to cancer or treatment complication

Conditions

Cancer Patients; Emergencies

Keywords

cancer; emergency departments (ED)

Outcome Measures

Primary Outcomes (1)

• Reasons for cancer patients to seek care in EDs

  1 day

Secondary Outcomes (4)

• cancer location

  1 day

• hospitalisation rate

  1 day

• intensive care unit (ICU) admission

  7 days

• ICU mortality

  7 days

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients of 18 years or more with active malignancy or in remission for less than 5 years and being attended in one of the 400 French emergency centers participating in the study during 3 consecutive days will be enrolled

You may qualify if:

• adult patients (age \>=18 years)
• with active malignancy or a history of cancer in remission within the last 5 years
• being attended in one of the 400 French emergency centers participating in the study during the 3-day study period

You may not qualify if:

• opposition to participate

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead

Study Sites (1)

Hôpital Saint Louis

Paris, 75010, France

Location

Related Publications (1)

• Peyrony O, Fontaine JP, Trabattoni E, Nakad L, Charreyre S, Picaud A, Bosc J, Viglino D, Jacquin L, Laribi S, Pereira L, Thiriez S, Paquet AL, Tanneau A, Azoulay E, Chevret S, Initiatives de Recherche Aux Urgences Iru-Sfmu Research Group. Cancer Patients' Prehospital Emergency Care: Post Hoc Analysis from the French Prospective Multicenter Study EPICANCER. J Clin Med. 2021 Mar 9;10(5):1145. doi: 10.3390/jcm10051145.

  PMID: 33803366 DERIVED

MeSH Terms

Conditions

Emergencies; Neoplasms

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Olivier Peyrony, MD

  Assistance Publique - Hôpitaux de Paris

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 20, 2017
• First Posted: January 8, 2018
• Study Start: February 6, 2018
• Primary Completion: February 9, 2018
• Study Completion: October 31, 2019
• Last Updated: January 7, 2020

Record last verified: 2019-12

Locations

FR (1)